Toft Group Executive Search has placed Ms. Diane Ingolia, JD, as Senior Director of Regulatory Affairs with Ascendis Pharma in Palo Alto, California. Ms. Ingolia comes to Ascendis with many years of experience in growing biotechnology companies with her expertise in regulatory affairs. She was most recently the Executive Director of Global Regulatory Affairs with Dermira, Inc. Previously, Ms. Ingolia held leadership positions in regulatory affairs with Affymax, Inc. and Genitope Corporation.
Ms. Ingolia holds a J.D. from Santa Clara University School of Law, a PhD in Biochemistry from Baylor College of Medicine, and a B.S. in Medical Technology from the University of New Orleans.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
About Ascendis Pharma
Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon™ technology to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three wholly-owned, independent rare disease endocrinology product candidates in clinical development. Additionally, Ascendis Pharma has multi-product collaborations with Sanofi in diabetes and Genentech in the field of ophthalmology and continues to expand into additional therapeutic areas for both internal and external development. Ascendis is headquartered in Copenhagen, Denmark, with offices in Heidelberg, Germany and Palo Alto, California.